Compliance With Dyslipidemia Guidelines in Daily Practice: How Effective Is Cardiovascular Risk Prevention?


GÜNTEKİN Ü., Gumrukcuoglu H. A. , Yaman M., Ozturk F., Akyol A., Gumrukcuoglu F. N. , ...More

CLINICAL THERAPEUTICS, vol.40, no.12, pp.2031-2040, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 40 Issue: 12
  • Publication Date: 2018
  • Doi Number: 10.1016/j.clinthera.2018.10.002
  • Journal Name: CLINICAL THERAPEUTICS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.2031-2040
  • Van Yüzüncü Yıl University Affiliated: Yes

Abstract

Purpose: Cardiovascular disease (CVD) due to atherosclerosis is the leading cause of early mortality and morbidity. The current European guidelines on CVD prevention in clinical practice recommend the use of the Systematic Coronary Risk Estimation (SCORE) system. The current American Heart Association guidelines recommend the use of the new pooled cohort risk assessment equations to estimate the 10-year atherosclerotic CVD risk. The purpose of this article was to investigate the compliance of dyslipidemia guidelines in daily practice in patients with dyslipidemia or who have risk factors for CVD.